Glaucoma is a group of eye conditions that damage the optic nerve, often due to elevated intraocular pressure (IOP). This damage can lead to vision loss and, in severe cases, blindness. Because glaucoma progresses gradually and often without noticeable symptoms, early detection and treatment are critical.

Medications

The first line of treatment for glaucoma often involves prescription eye drops or oral medications designed to lower IOP. These medications work by either reducing the production of fluid in the eye or improving its outflow. Commonly prescribed medications include prostaglandin analogs, beta-blockers, and carbonic anhydrase inhibitors.

Laser Therapy

For patients who do not achieve sufficient IOP control with medications, laser therapy can be a highly effective option. Procedures such as selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT) target the drainage system of the eye to improve fluid outflow and reduce IOP. These treatments are minimally invasive and have become a cornerstone of modern glaucoma management.

Advancements Driving Glaucoma Treatment in 2025

When medications and laser therapy are no longer sufficient, surgical options represent the most advanced interventions available. In 2025, innovations in glaucoma surgery have made these procedures more effective and less invasive than ever.

Trabeculectomy

Trabeculectomy is a surgical procedure in which a small opening is created in the eye to allow excess fluid to drain more efficiently. This helps reduce intraocular pressure (IOP), making it an effective treatment for advanced glaucoma when other methods, such as medications or laser therapy, have not been sufficient. Trabeculectomy has been a standard surgical option for decades and continues to be a reliable solution for managing glaucoma.

Shunt Implantation

Shunt implantation involves the placement of tiny, biocompatible devices like the Xen Gel Stent or the Ahmed Glaucoma Valve into the eye to regulate fluid outflow. These advanced implants have revolutionized glaucoma surgery by offering safer, more predictable outcomes. By controlling fluid drainage, these devices help maintain lower IOP and reduce the risk of further optic nerve damage, making them an excellent choice for patients who need more long-term IOP management.

Minimally Invasive Glaucoma Surgery (MIGS)

Minimally Invasive Glaucoma Surgery (MIGS) represents a groundbreaking approach to glaucoma treatment, particularly for patients with mild to moderate cases. Procedures are designed to enhance fluid outflow with minimal disruption to the eye’s natural structures. MIGS offers numerous benefits, including quicker recovery times, fewer complications, and improved patient satisfaction compared to traditional surgical techniques, making it an increasingly popular choice among eye care professionals and patients alike.

Schedule Your Glaucoma Screening Today

Glaucoma is a serious condition that requires proactive management to protect vision. From medications and laser therapies to cutting-edge surgical options, advancements in glaucoma treatment offer hope for better outcomes and improved quality of life. By working closely with your doctor, patients can determine the best treatment plan for their specific situation.

If you’re concerned about your risk for glaucoma, schedule a comprehensive eye exam with Opticore Optometry Group. Contact our office in Chino, Redlands, Fontana, or Riverside, California, by calling (866) 202-2221 to book an appointment today.